汇添富中证中药ETF(560080)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
-101,224,736.67 |
-56,872,485.83 |
-88,978,497.55 |
-221,647,392.54 |
| 利息合计 |
63,559.44 |
26,847.27 |
928,954.63 |
897,092.66 |
| 其中:存款利息收入 |
62,697.99 |
25,985.82 |
69,608.23 |
37,746.26 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
861.45 |
861.45 |
- |
- |
| 投资收益合计 |
-65,617,692.98 |
-48,463,088.82 |
-106,989,263.75 |
-70,228,554.45 |
| 其中:股票投资收益 |
-119,823,233.05 |
-74,798,824.16 |
-167,158,871.85 |
-105,068,934.25 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
54,205,540.07 |
26,335,735.34 |
60,169,608.10 |
34,840,379.80 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-36,701,347.57 |
-9,031,102.74 |
16,174,717.31 |
-153,265,829.28 |
| 其他收入 |
1,030,744.44 |
594,858.46 |
907,094.26 |
949,898.53 |
| 费用 |
13,235,726.17 |
5,912,991.30 |
12,027,874.38 |
5,765,788.54 |
| 管理人报酬 |
10,857,486.20 |
4,842,682.88 |
9,866,621.07 |
4,721,622.63 |
| 基金托管费 |
2,171,497.28 |
968,536.60 |
1,973,324.13 |
944,324.53 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
206,742.67 |
101,771.80 |
184,835.26 |
96,747.46 |
| 利润总额 |
-114,460,462.84 |
-62,785,477.13 |
-101,006,371.93 |
-227,413,181.08 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年